Discover
ESLA
Estrella Immunopharma, Inc.
0.80
1 x 0.81
1 x 0.85
bid
ask
-
0.02
3.02%
04:00 PM
| Ytd | -48.72% | |
| 1y | -4.76% |
0.78
day range
0.83
0.73
52 week range
3.15
| Open | 0.80 | Prev Close | 0.82 | Low | 0.78 | High | 0.83 | Mkt Cap | 34.43M |
| Vol | 26.78K | Avg Vol | 42.95K | EPS | -0.35 | P/E | -2.31 | Forward P/E | N/A |
| Beta | 0.85 | Short Ratio | 0.07 | Inst. Own | 0.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.03 | 200-d Avg | 1.42 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Geode Capital Management, LLC | 76.56K | 86.51K | 0.21% |
| 2024-09-29 | ATW Spac Management LLC | 40.00K | 45.20K | 0.11% |
| 2024-09-29 | Blackrock Inc. | 24.96K | 28.21K | 0.07% |
| 2024-09-29 | Vanguard Group Inc | 21.68K | 24.50K | 0.06% |
| 2024-09-29 | Citadel Advisors Llc | 14.53K | 16.42K | 0.04% |
| 2024-09-29 | Maso Capital Partners Ltd. | 10.00K | 11.30K | 0.03% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 56.78K | 64.16K | 0.16% |
| 2024-10-30 | iShares Micro Cap ETF | 22.44K | 25.35K | 0.06% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 17.97K | 20.30K | 0.05% |
| 2024-10-30 | Fidelity Total Market Index Fund | 16.86K | 19.05K | 0.05% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 13.41K | 15.16K | 0.04% |
| 2024-09-29 | EQ Advisors Trust-1290 VT Micro Cap Port | 2.37K | 2.68K | 0.01% |